Versant Ventures
Overview
Versant Ventures is a healthcare investment firm that specializes in venture capital investments in biotechnology companies discovering and developing novel therapeutics.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Jade Biosciences, Inc. | Oct 2024 | Convertible Debt | Co-investor |
| Aligos Therapeutics | Jan 2020 | Series B | Co-investor |
| Oyster Point Medical LLC | Feb 2019 | Series B | Co-investor |
| Lycia Therapeutics | Sep 2021 | Series B | Co-investor |
| Gate Bioscience | Nov 2025 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Barbara Lubash
Managing Director (Emeritus) and Co-Founder
Beckie Robertson
Founder And General Partner
Don Milder
Managing Partner
Alex Mayweg
Managing Director
Brad Bolzon
Chairman and Managing Director
Carlo Rizzuto
Managing Director
Clare Ozawa
Managing Director
Jerel Davis
Managing Director
Tom Woiwode
Managing Director
Giorgio Ottaviani
Operating Partner
Kevin Grove
Venture Partner
Markus Warmuth
Venture Partner
Monal Mehta
Venture Partner
Thomas Hudson
Venture Partner
Zachary Sweeney
Venture Partner
Markus Enzelberger
Partner
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Versant Ventures based?
Versant Ventures is headquartered in San Francisco, California, United States.
When was Versant Ventures founded?
Versant Ventures was founded in 1999.
How many portfolio companies does Versant Ventures have?
Versant Ventures has 92 portfolio companies in Caplight's dataset.
What are some companies in Versant Ventures's portfolio?
Portfolio companies visible on Caplight include Jade Biosciences, Inc., Aligos Therapeutics, Oyster Point Medical LLC, Lycia Therapeutics, Gate Bioscience.
What was Versant Ventures's most recent investment shown here?
Versant Ventures's most recent investment in this portfolio sample was in Gate Bioscience in 2025.
What sectors does Versant Ventures focus on?
Versant Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Real Estate & PropTech, Energy & Sustainability, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Versant Ventures focus on?
Versant Ventures typically invests at the Early stage.
What is Versant Ventures's AUM?
Versant Ventures's assets under management are estimated between $1.0B and $10.0B.